je.st
news
Launch Delays The Wrong Prescription For GenMark Shares
2015-10-06 22:39:33| Biotech - Topix.net
Every market day, we select up to 20 of our authors' top long and short ideas, exclusively for PRO subscribers. A commercialization delay announced back in April has kept GenMark in the market's penalty box while rival BioMerieux has continued to see strong FilmArray adoption and use.
Tags: wrong
shares
launch
prescription
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|